title: Anemia Management in the China Dialysis Outcomes and Practice Patterns Study.
abstract: BACKGROUND
  As the utilization of hemodialysis increases in China, it is critical to examine anemia management.
  
  
  METHODS
  Using data from the China Dialysis Outcomes and Practice Patterns Study (DOPPS), we describe hemoglobin (Hgb) distribution and anemia-related therapies.
  
  
  RESULTS
  Twenty one percent of China's DOPPS patients had Hgb <9 g/dl, compared with ≤10% in Japan and North America. A majority of medical directors targeted Hgb ≥11. Patients who were female, younger, or recently hospitalized had higher odds of Hgb <9; those with insurance coverage or on twice weekly dialysis had lower odds of Hgb <9. Iron use and erythropoietin-stimulating agents (ESAs) dose were modestly higher for patients with Hgb <9 compared with Hgb in the range 10-12.
  
  
  CONCLUSIONS
  A large proportion of hemodialysis patients in China's DOPPS do not meet the expressed Hgb targets. Less frequent hemodialysis, patient financial contribution, and lack of a substantial increase in ESA dose at lower Hgb concentrations may partially explain this gap. Video Journal Club 'Cappuccino with Claudio Ronco' at http://www.karger.com/?doi=442741.
authors.affiliation: Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
authors.forename: Li
authors.initials: L
authors.lastname: Zuo
authors.forename: Mia
authors.initials: M
authors.lastname: Wang
authors.forename: Fanfan
authors.initials: F
authors.lastname: Hou
authors.forename: Yucheng
authors.initials: Y
authors.lastname: Yan
authors.forename: Nan
authors.initials: N
authors.lastname: Chen
authors.forename: Jiaqi
authors.initials: J
authors.lastname: Qian
authors.forename: Mei
authors.initials: M
authors.lastname: Wang
authors.forename: Brian
authors.initials: B
authors.lastname: Bieber
authors.forename: Ronald L
authors.initials: RL
authors.lastname: Pisoni
authors.forename: Bruce M
authors.initials: BM
authors.lastname: Robinson
authors.forename: Shuchi
authors.initials: S
authors.lastname: Anand
mesh_terms: D000368:Aged; D000740:Anemia / Q000628:therapy*; D002681:China; D003430:Cross-Sectional Studies; D019468:Disease Management; D004921:Erythropoietin; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D006435:Renal Dialysis / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D006454:Hemoglobins; D004921:Erythropoietin